Getinge publishes its Sustainability Report 2022

Getinge’s 2022 Sustainability Report presents how the company is taking important steps to reach the long- and short-term sustainability targets. In 2022, Getinge submitted its environmental targets for validation to the Science Based Target initiative, and decreased the CO₂ emissions by 48% in 2022 compared to 2021, while continuing to supporting customers and society at large.

As a global medtech company, Getinge’s impact is inherently a social one - to help improve and save people’s lives. The company relies on innovation, science and technology to address some of society’s most challenging healthcare issues such as heart-lung diseases and healthcare acquired infections. A growing and ageing population is putting increased pressure on financial, human and natural resources in healthcare and the medtech industry.

“Sustainability is not a separate activity,” says Anna Romberg, Executive Vice President Sustainability, Legal & Compliance at Getinge. “Being a medtech company, it is ingrained in everything we do. Our passion for life extends beyond the immediate impact of our products and we strive to be an agent of positive change, both for the people in this world and for the planet itself.”

Getinge’s Sustainability Report is focused on material topics around the four strategic pillars of the company’s sustainability efforts for 2022: Quality culture, Passionate employees, Business ethics and Responsible leadership and Environmental and social engagement.

Some key highlights of Getinge’s sustainability work 2022 are:

• Getinge is committed to Science Based Target initiative (SBTi) and during 2022 the company’s environmental targets were submitted for validation. The long-term target is to become a net zero company by 2050, with the short-term target of becoming CO₂ neutral without offsetting in own production by 2025. The company is progressing well and has lowered the CO₂ emissions by 48% in 2022 compared to 2021. Getinge has also established a base line year (2021) for its Scope 3 emissions
   
• A study published in the Journal of Clinical Monitoring and Computing which demonstrated that the unique Automatic Gas Control (AGC) in Getinge’s anesthesia machine Flow-i can help hospitals to reduce their anesthesia emissions by up to 58%

• A case study at SRH Klinikum Karlsbad-Langensteinbach in Germany revealed that the installation of Getinge's sterile reprocessing solutions achieved savings of time, cost and water consumption as well as improved safety for patients and employees

• The company showed good progress in diversity and equal opportunities and increased the gender balance in top management. In 2022, the top management consisted of 55% male employees and 45% female employees. This progress was recognized by the Allbright report, where Getinge climbed up to 13th place (from 129 in 2021) on the list of Green companies*)
   
• Getinge’s Business Ethics & Responsible leadership goal of making sure that all employees are properly trained in business ethics, reached 90% of all employees during 2022

• Over 52,000 online customer trainings were conducted during 2022

The 2022 Sustainability Report is available at www.getinge.com.

*Defined as companies that reach gender equality of at least 60% male and 40% female in top management

Media Contact:

Anna Appelqvist, VP Corporate Communications
Tel.: +46 (0)10-335 5906
E-mail: anna.appelqvist@getinge.com

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.

Tags: